Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Cytovance Biologics and PolyPeptide Announce Collaboration for Microbial and Mammalian-Expressed Peptide Drugs

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Research
Other Health
Pharmaceutical
Oncology
Other Manufacturing
Science
Cardiology
Chemicals/Plastics
Biotechnology
Health
Diabetes
Other Science
Manufacturing
Cytovance Biologics

More Like This

PR Newswire associated0

CordenPharma and Viking Therapeutics Sign Long-Term Strategic Partnership for Integrated Supply of GLP-1 Peptides, Injectables and Oral Formulations

ACCESS Newswire associated0

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

PR Newswire associated0

Chime Biologics Partners Polpharma Biologics to Advance Global Biosimilar Development

Business Wire logo

Altasciences and VoxCell BioInnovation Announce Strategic Collaboration to Advance Preclinical Drug Development

PR Newswire associated0

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing

Intravacc and Primrose Bio Announce Partnership to Enhance Conjugate Vaccine Development

Business Wire logo

Polpharma Biologics and Fresenius Kabi Sign Licensing Agreement for Proposed Vedolizumab Biosimilar PB016

Biesterfeld and Celanese: global expansion and enhanced joint portfolio as of 2024

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us